Light chain systemic amyloidosis has low clinical incidence rate and poor prognosis. Relevant diagnosis depends on the biopsy results, and many patients were not confirmed until autopsy. Once amyloidosis is suspected, it is necessary to communicate with their families on the risks for treatment methods and prognosis.